Cargando…
Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report
• Treatment of sex-cord stromal tumors with carboplatin and taxane is both feasible and safe. • FOXL2 mutations account for approximately 50% of these tumors. • Carboplatin and taxane may afford a favorable outcome.
Autores principales: | Brightwell, Rachel, Grzankowski, Kassondra, Kasznica, John, Frederick, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688826/ https://www.ncbi.nlm.nih.gov/pubmed/26793762 http://dx.doi.org/10.1016/j.gore.2015.08.001 |
Ejemplares similares
-
Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator
por: Grzankowski, Kassondra S., et al.
Publicado: (2014) -
Poorly differentiated, ovarian Sertoli-Leydig cell tumor with heterologous rhabdomyosarcoma and glandular elements: Diagnosis and management of a rare neoplasm
por: Singh, Charanjeet, et al.
Publicado: (2018) -
Frozen Section Diagnostic Pitfalls of Sertoli-Leydig Cell Tumor with Heterologous Elements
por: Burris, Ashley, et al.
Publicado: (2018) -
Poorly Differentiated Ovarian Sertoli–Leydig Cell Tumor in a 12-Month-Old Girl
por: Chauhan, Kriti, et al.
Publicado: (2020) -
Successful term pregnancies after laparoscopic excision of poorly differentiated Sertoli-Leydig cell tumor of the ovary
por: Gowri, Vaidyanathan, et al.
Publicado: (2012)